In this study, we investigated the environmental impacts of a case study process for the synthesis of paracetamol from CST-derived β-pinene. With a production volume exceeding 100 000 t/y, paracetamol is one of the most commonly sold over-the-counter drugs and represents a key active ingredient within the pharmaceutical industry. Industrially, paracetamol is widely synthesised via N-acetylation of 4-aminophenol, which can be obtained from the benzene derivatives nitrobenzene, 4-nitrophenol and 4nitrochlorobenzene through various chemical routes. Another established paracetamol synthesis method is the Hoechst-Celanese process, where the substrate 4hydroxyacetophenone is also generally manufactured from benzene derivatives such as phenol. Since benzene is conventionally gained from crude oil, current paracetamol manufacture is essentially based on fossil feedstocks. This dependency on fossil-derived feedstock compounds in the synthesis of functionalised molecules is an industry-wide issue that incurs hard-to-abate carbon emissions across the upstream manufacturing process. The resulting presence of embedded carbon in the final product molecule contributes to Scope 3 emissions which typically constitute the largest proportion of emissions across a product's life cycle evaluation. As such, a new pathway for paracetamol synthesis from bio-waste β-pinene feedstock that has reduced environmental impacts would support a transition away from petrochemical dependence and promote the bio-based manufacture of functionalised molecules.